Corporate News 02-Apr-21
Syngene International acquires 7.78% stake in Immuneel Therapeutics
Syngene International announced that the Compulsorily Convertible Debentures of Immuneel Therapeutics have been converted into equity shares resulting in acquisition of 7.78% shareholding by the company in Immuneel Therapeutics.
Previous News
Syngene International consolidated net profit rises 20.91% in the March 2023 quarter
( Results - Announcements 27-Apr-23 07:42 )
Syngene International
( Results - Analysis 27-Jul-23 11:11 )
Board of Syngene International recommends Special Dividend
( Corporate News - 27-Apr-23 10:09 )
Board of Syngene International recommends Final Dividend
( Corporate News - 27-Apr-23 10:09 )
Syngene International to hold board meeting
( Corporate News - 01-Apr-24 17:38 )
Syngene International consolidated net profit rises 1.64% in the December 2023 quarter
( Results - Announcements 25-Jan-24 15:21 )
Syngene International consolidated net profit rises 1.76% in the December 2021 quarter
( Results - Announcements 20-Jan-22 08:04 )
Syngene International
( Analyst Meet / AGM - Conference Call 13-May-20 17:53 )
Syngene International schedules AGM
( Corporate News - 28-Apr-21 18:34 )
Volumes soar at Syngene International Ltd counter
( Hot Pursuit - 01-Feb-23 11:00 )
Volumes soar at Syngene International Ltd counter
( Hot Pursuit - 10-Sep-20 14:30 )
Other Stories
John Cockerill India to declare Quarterly Result
08-Jul-24 14:58
Kumbhat Financial Services to conduct board meeting
08-Jul-24 14:58
D-Link (India) announces board meeting date
08-Jul-24 14:58
AAVAS Financiers to hold AGM
08-Jul-24 13:47
Pudumjee Paper Products to hold AGM
08-Jul-24 13:47
Hemadri Cements AGM scheduled
08-Jul-24 13:47
Vertoz Advertising AGM scheduled
08-Jul-24 13:47
Menon Bearings to announce Quarterly Result
08-Jul-24 13:37
K&R Rail Engg. to discuss results
08-Jul-24 13:37
Rajoo Engineers to declare Quarterly Result
08-Jul-24 13:37
Back
Top
